This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAMIN 10 MG TAB is a generic product labeled by Sandoz Inc., priced at $0.2327 per EA under NDC 00185084201. Its NADAC has been published 530 times since Aug 10, 2016.
FDA first approved this application on Jun 14, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHETAMIN 10 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Sandoz Inc.NDC
00185084201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040439FDA Approved
6/14/2002
TE Code
AB
On Market Since
6/14/2002
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has been published 530 times since Aug 10, 2016, and over the history we have for it it has declined 57.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2327 per EA |
|---|---|
| All-time high | $0.6361 (Sep 14, 2016) |
| All-time low | $0.1975 (Nov 20, 2024) |
| 52-week high | $0.2513 |
| 52-week low | $0.2327 |
| Median price | $0.2881 |
| Average price | $0.3429 |
| Largest weekly change | +39.7% (May 17, 2023) |
| Weeks tracked | 530 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 10 MG TAB, manufactured by Sandoz Inc., is $0.2327 per EA (NDC 00185084201), effective Sep 30, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 10 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has declined 57.7%. It has been tracked across 530 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 10 MG TAB?
Since Aug 10, 2016, the NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has ranged from a low of $0.1975 (Nov 20, 2024) to a high of $0.6361 (Sep 14, 2016), with a median of $0.2881 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 10 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 10 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMIN 10 MG TAB?
DEXTROAMP-AMPHETAMIN 10 MG TAB (NDC 00185084201) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAMIN 10 MG TAB in shortage?
Yes — NDC 00185084201 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).